Overview

Blocking the Effects of Serotonin to Prevent Ischemic Mitral Regurgitation: a Randomized Trial

Status:
Not yet recruiting
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
This study is intended to investigate the effect of cyproheptadine (a 5HT2B receptor blocker) on mitral regurgitation severity.
Phase:
Phase 2
Details
Lead Sponsor:
Laval University
Collaborator:
Canadian Institutes of Health Research (CIHR)
Treatments:
Cyproheptadine